Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Pulmonary Hypertension

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 108 articles:
HTML format
Text format



Single Articles


    January 2019
  1. NAITO A, Hiwasa T, Tanabe N, Sanada TJ, et al
    Elevated levels of autoantibodies against EXD2 and PHAX in the sera of patients with chronic thromboembolic pulmonary hypertension.
    PLoS One. 2019;14:e0211377.
    PubMed     Text format     Abstract available


  2. POWER AS, Norman R, Jones TLM, Hickey AJ, et al
    Mitochondrial function remains impaired in the hypertrophied right ventricle of pulmonary hypertensive rats following short duration metoprolol treatment.
    PLoS One. 2019;14:e0214740.
    PubMed     Text format     Abstract available


  3. COTTIN V, Avot D, Levy-Bachelot L, Baxter CA, et al
    Identifying chronic thromboembolic pulmonary hypertension through the French national hospital discharge database.
    PLoS One. 2019;14:e0214649.
    PubMed     Text format     Abstract available


  4. DAVIS EM, Baust JJ, O'Donnell BJ, Shah FA, et al
    Correction: A phenotype of increased sleepiness in a mouse model of pulmonary hypertension and right ventricular hypertrophy.
    PLoS One. 2019;14:e0218401.
    PubMed     Text format     Abstract available


    January 2018
  5. DEY S, Parveen A, Tarrant KJ, Licknack T, et al
    Whole genome resequencing identifies the CPQ gene as a determinant of ascites syndrome in broilers.
    PLoS One. 2018;13:e0189544.
    PubMed     Text format     Abstract available


  6. GREINER S, Jud A, Aurich M, Geisenberger C, et al
    Prognostic relevance of elevated pulmonary arterial pressure assessed non-invasively: Analysis in a large patient cohort with invasive measurements in near temporal proximity.
    PLoS One. 2018;13:e0191206.
    PubMed     Text format     Abstract available


  7. CHAMORRO V, Morales-Cano D, Milara J, Barreira B, et al
    Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matching.
    PLoS One. 2018;13:e0191239.
    PubMed     Text format     Abstract available


  8. KHIRFAN G, Naal T, Abuhalimeh B, Newman J, et al
    Hypoxemia in patients with idiopathic or heritable pulmonary arterial hypertension.
    PLoS One. 2018;13:e0191869.
    PubMed     Text format     Abstract available


  9. ALENCAR AK, Carvalho FI, Silva AM, Martinez ST, et al
    Synergistic interaction between a PDE5 inhibitor (sildenafil) and a new adenosine A2A receptor agonist (LASSBio-1359) improves pulmonary hypertension in rats.
    PLoS One. 2018;13:e0195047.
    PubMed     Text format     Abstract available


  10. LAUNAY D, Montani D, Hassoun PM, Cottin V, et al
    Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis.
    PLoS One. 2018;13:e0197112.
    PubMed     Text format     Abstract available


  11. KHIRFAN G, Tejwani V, Wang X, Li M, et al
    Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension.
    PLoS One. 2018;13:e0197700.
    PubMed     Text format     Abstract available


  12. CARAVITA S, Faini A, Carolino D'Araujo S, Dewachter C, et al
    Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
    PLoS One. 2018;13:e0199164.
    PubMed     Text format     Abstract available


  13. SOUZA R, Channick RN, Delcroix M, Galie N, et al
    Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial.
    PLoS One. 2018;13:e0193226.
    PubMed     Text format     Abstract available


  14. DONDA K, Zambrano R, Moon Y, Percival J, et al
    Riociguat prevents hyperoxia-induced lung injury and pulmonary hypertension in neonatal rats without effects on long bone growth.
    PLoS One. 2018;13:e0199927.
    PubMed     Text format     Abstract available


  15. STEPNOWSKA E, Lewicka E, Dabrowska-Kugacka A, Danilowicz-Szymanowicz L, et al
    Predictors of poor outcome in patients with pulmonary arterial hypertension: A single center study.
    PLoS One. 2018;13:e0193245.
    PubMed     Text format     Abstract available


  16. MIHARA K, Ogawa A, Matsubara H, Terao T, et al
    Investigation of safety and efficacy of the new more thermostable formulation of Flolan (epoprostenol) in Japanese patients with pulmonary arterial hypertension (PAH)-An open-label, single-arm study.
    PLoS One. 2018;13:e0195195.
    PubMed     Text format     Abstract available


  17. GROSSE A, Grosse C, Lang I
    Evaluation of the CT imaging findings in patients newly diagnosed with chronic thromboembolic pulmonary hypertension.
    PLoS One. 2018;13:e0201468.
    PubMed     Text format     Abstract available


  18. VIJARNSORN C, Durongpisitkul K, Chungsomprasong P, Bositthipichet D, et al
    Contemporary survival of patients with pulmonary arterial hypertension and congenital systemic to pulmonary shunts.
    PLoS One. 2018;13:e0195092.
    PubMed     Text format     Abstract available


  19. WILSON JL, Warburton R, Taylor L, Toksoz D, et al
    Unraveling endothelin-1 induced hypercontractility of human pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension.
    PLoS One. 2018;13:e0195780.
    PubMed     Text format     Abstract available


  20. SHAH AC, Ma K, Faraoni D, Oh DCS, et al
    Self-reported functional status predicts post-operative outcomes in non-cardiac surgery patients with pulmonary hypertension.
    PLoS One. 2018;13:e0201914.
    PubMed     Text format     Abstract available


  21. SONNWEBER T, Nairz M, Theurl I, Petzer V, et al
    The crucial impact of iron deficiency definition for the course of precapillary pulmonary hypertension.
    PLoS One. 2018;13:e0203396.
    PubMed     Text format     Abstract available


  22. ROLIM JV, Ota-Arakaki JS, Ferreira EVM, Figliolino GAM, et al
    Inspiratory muscle weakness contributes to exertional dyspnea in chronic thromboembolic pulmonary hypertension.
    PLoS One. 2018;13:e0204072.
    PubMed     Text format     Abstract available


  23. KRIECHBAUM SD, Wiedenroth CB, Keller T, Wolter JS, et al
    Dynamics of high-sensitivity cardiac troponin T during therapy with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
    PLoS One. 2018;13:e0204683.
    PubMed     Text format     Abstract available


  24. GUAY CA, Morin-Thibault LV, Bonnet S, Lacasse Y, et al
    Pulmonary hypertension-targeted therapies in heart failure: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0204610.
    PubMed     Text format     Abstract available


  25. TAKAHASHI T, Yoshihisa A, Sugimoto K, Yokokawa T, et al
    Associations between diabetes mellitus and pulmonary hypertension in chronic respiratory disease patients.
    PLoS One. 2018;13:e0205008.
    PubMed     Text format     Abstract available


  26. DRIESSEN MMP, Leiner T, Sieswerda GT, van Dijk APJ, et al
    RV adaptation to increased afterload in congenital heart disease and pulmonary hypertension.
    PLoS One. 2018;13:e0205196.
    PubMed     Text format     Abstract available


  27. SATO T, Hatano M, Iwasaki Y, Maki H, et al
    Prevalence of primary Sjogren's syndrome in patients undergoing evaluation for pulmonary arterial hypertension.
    PLoS One. 2018;13:e0197297.
    PubMed     Text format     Abstract available


  28. IGATA S, Tahara N, Sugiyama Y, Bekki M, et al
    Utility of the amplitude of RV1+SV5/6 in assessment of pulmonary hypertension.
    PLoS One. 2018;13:e0206856.
    PubMed     Text format     Abstract available


  29. GHIO S, Crimi G, Pica S, Temporelli PL, et al
    Correction: Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension.
    PLoS One. 2018;13:e0208863.
    PubMed     Text format     Abstract available


  30. DAVIS EM, Baust JJ, O'Donnell BJ, Shah FA, et al
    A phenotype of increased sleepiness in a mouse model of pulmonary hypertension and right ventricular hypertrophy.
    PLoS One. 2018;13:e0208540.
    PubMed     Text format     Abstract available


  31. TROMEUR C, Jais X, Mercier O, Couturaud F, et al
    Factors predicting outcome after pulmonary endarterectomy.
    PLoS One. 2018;13:e0198198.
    PubMed     Text format     Abstract available


  32. KURDYUKOV S, Eccles CA, Desai AA, Gonzalez-Garay M, et al
    New cases of Glucose-6-Phosphate Dehydrogenase deficiency in Pulmonary Arterial Hypertension.
    PLoS One. 2018;13:e0203493.
    PubMed     Text format     Abstract available


  33. NAKAMURA K, Sakaguchi M, Matsubara H, Akagi S, et al
    Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension.
    PLoS One. 2018;13:e0203046.
    PubMed     Text format     Abstract available


  34. FUJITA N, Yamasaki N, Eto K, Asaeda M, et al
    Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension.
    PLoS One. 2018;13:e0204254.
    PubMed     Text format     Abstract available


  35. ZANTE B, Reichenspurner H, Kubik M, Kluge S, et al
    Base excess is superior to lactate-levels in prediction of ICU mortality after cardiac surgery.
    PLoS One. 2018;13:e0205309.
    PubMed     Text format     Abstract available


  36. LAMBERS C, Kornauth C, Oberndorfer F, Boehm PM, et al
    Mechanism of anti-remodelling action of treprostinil in human pulmonary arterial smooth muscle cells.
    PLoS One. 2018;13:e0205195.
    PubMed     Text format     Abstract available


  37. HOFFMANN-VOLD AM, Weigt SS, Palchevskiy V, Volkmann E, et al
    Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis.
    PLoS One. 2018;13:e0206545.
    PubMed     Text format     Abstract available


  38. SONG S, Lee SE, Oh SK, Jeon SA, et al
    Demographics, treatment trends, and survival rate in incident pulmonary artery hypertension in Korea: A nationwide study based on the health insurance review and assessment service database.
    PLoS One. 2018;13:e0209148.
    PubMed     Text format     Abstract available


    January 2017
  39. GOTTING M, Schwarzer M, Gerber A, Klingelhofer D, et al
    Pulmonary Hypertension: Scientometric Analysis and Density-Equalizing Mapping.
    PLoS One. 2017;12:e0169238.
    PubMed     Text format     Abstract available


  40. HIMORI K, Abe M, Tatebayashi D, Lee J, et al
    Superoxide dismutase/catalase mimetic EUK-134 prevents diaphragm muscle weakness in monocrotalin-induced pulmonary hypertension.
    PLoS One. 2017;12:e0169146.
    PubMed     Text format     Abstract available


  41. DUMAS DE LA ROQUE E, Smeralda G, Quignard JF, Freund-Michel V, et al
    Altered vasoreactivity in neonatal rats with pulmonary hypertension associated with bronchopulmonary dysplasia: Implication of both eNOS phosphorylation and calcium signaling.
    PLoS One. 2017;12:e0173044.
    PubMed     Text format     Abstract available


  42. WANG X, Shults NV, Suzuki YJ
    Oxidative profiling of the failing right heart in rats with pulmonary hypertension.
    PLoS One. 2017;12:e0176887.
    PubMed     Text format     Abstract available


  43. TANAKA H, Kataoka M, Isobe S, Yamamoto T, et al
    Therapeutic impact of dietary vitamin D supplementation for preventing right ventricular remodeling and improving survival in pulmonary hypertension.
    PLoS One. 2017;12:e0180615.
    PubMed     Text format     Abstract available


  44. PEREZ M, Lee KJ, Cardona HJ, Taylor JM, et al
    Aberrant cGMP signaling persists during recovery in mice with oxygen-induced pulmonary hypertension.
    PLoS One. 2017;12:e0180957.
    PubMed     Text format     Abstract available


  45. SZEMA AM, Forsyth E, Ying B, Hamidi SA, et al
    NFATc3 and VIP in Idiopathic Pulmonary Fibrosis and Chronic Obstructive Pulmonary Disease.
    PLoS One. 2017;12:e0170606.
    PubMed     Text format     Abstract available


  46. MIDDLETON RC, Fournier M, Xu X, Marban E, et al
    Therapeutic benefits of intravenous cardiosphere-derived cell therapy in rats with pulmonary hypertension.
    PLoS One. 2017;12:e0183557.
    PubMed     Text format     Abstract available


  47. LOOMIS Z, Eigenberger P, Redinius K, Lisk C, et al
    Hemoglobin induced cell trauma indirectly influences endothelial TLR9 activity resulting in pulmonary vascular smooth muscle cell activation.
    PLoS One. 2017;12:e0171219.
    PubMed     Text format     Abstract available


  48. POOR HD, Kawut SM, Liu CY, Smith BM, et al
    Pulmonary hyperinflation due to gas trapping and pulmonary artery size: The MESA COPD Study.
    PLoS One. 2017;12:e0176812.
    PubMed     Text format     Abstract available


  49. SOKUNBI OJ, Ekure EN, Temiye EO, Anyanwu R, et al
    Pulmonary hypertension among 5 to 18 year old children with sickle cell anaemia in Nigeria.
    PLoS One. 2017;12:e0184287.
    PubMed     Text format     Abstract available


  50. LAN CC, Peng CK, Tang SE, Huang KL, et al
    Carbonic anhydrase inhibitor attenuates ischemia-reperfusion induced acute lung injury.
    PLoS One. 2017;12:e0179822.
    PubMed     Text format     Abstract available


  51. FUCHS H, Rossmann N, Schmid MB, Hoenig M, et al
    Permissive hypercapnia for severe acute respiratory distress syndrome in immunocompromised children: A single center experience.
    PLoS One. 2017;12:e0179974.
    PubMed     Text format     Abstract available


  52. REVUZ S, Decullier E, Ginon I, Lamblin N, et al
    Pulmonary hypertension subtypes associated with hereditary haemorrhagic telangiectasia: Haemodynamic profiles and survival probability.
    PLoS One. 2017;12:e0184227.
    PubMed     Text format     Abstract available


  53. JERNIGAN NL, Naik JS, Weise-Cross L, Detweiler ND, et al
    Contribution of reactive oxygen species to the pathogenesis of pulmonary arterial hypertension.
    PLoS One. 2017;12:e0180455.
    PubMed     Text format     Abstract available


  54. ZUNGU-EDMONDSON M, Shults NV, Melnyk O, Suzuki YJ, et al
    Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats.
    PLoS One. 2017;12:e0182551.
    PubMed     Text format     Abstract available


  55. LE GOUELLEC N, Duhamel A, Perez T, Hachulla AL, et al
    Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease.
    PLoS One. 2017;12:e0181692.
    PubMed     Text format     Abstract available


  56. SUGIMOTO K, Nakazato K, Sato A, Suzuki S, et al
    Autoimmune disease mouse model exhibits pulmonary arterial hypertension.
    PLoS One. 2017;12:e0184990.
    PubMed     Text format     Abstract available


  57. VENTETUOLO CE, Hess E, Austin ED, Baron AE, et al
    Sex-based differences in veterans with pulmonary hypertension: Results from the veterans affairs-clinical assessment reporting and tracking database.
    PLoS One. 2017;12:e0187734.
    PubMed     Text format     Abstract available


  58. SATO T, Tsujino I, Ohira H, Oyama-Manabe N, et al
    Accuracy of echocardiographic indices for serial monitoring of right ventricular systolic function in patients with precapillary pulmonary hypertension.
    PLoS One. 2017;12:e0187806.
    PubMed     Text format     Abstract available


  59. GHIO S, Crimi G, Pica S, Temporelli PL, et al
    Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension.
    PLoS One. 2017;12:e0188383.
    PubMed     Text format     Abstract available


  60. LOPEZ-MESEGUER M, Quezada CA, Ramon MA, Lazaro M, et al
    Lung and heart-lung transplantation in pulmonary arterial hypertension.
    PLoS One. 2017;12:e0187811.
    PubMed     Text format     Abstract available


    January 2016
  61. XI Q, Liu Z, Zhao Z, Luo Q, et al
    High Frequency of Pulmonary Hypertension-Causing Gene Mutation in Chinese Patients with Chronic Thromboembolic Pulmonary Hypertension.
    PLoS One. 2016;11:e0147396.
    PubMed     Text format     Abstract available


  62. GUBRIJ IB, Pangle AK, Pang L, Johnson LG, et al
    Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension.
    PLoS One. 2016;11:e0147827.
    PubMed     Text format     Abstract available


  63. LI Q, Mao M, Qiu Y, Liu G, et al
    Key Role of ROS in the Process of 15-Lipoxygenase/15-Hydroxyeicosatetraenoiccid-Induced Pulmonary Vascular Remodeling in Hypoxia Pulmonary Hypertension.
    PLoS One. 2016;11:e0149164.
    PubMed     Text format     Abstract available


  64. RAFIKOVA O, Meadows ML, Kinchen JM, Mohney RP, et al
    Metabolic Changes Precede the Development of Pulmonary Hypertension in the Monocrotaline Exposed Rat Lung.
    PLoS One. 2016;11:e0150480.
    PubMed     Text format     Abstract available


  65. RICHTER MJ, Milger K, Haase S, Sommer N, et al
    The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension.
    PLoS One. 2016;11:e0152580.
    PubMed     Text format     Abstract available


  66. YIN X, Wang L, Qin G, Luo H, et al
    Rats with Chronic, Stable Pulmonary Hypertension Tolerate Low Dose Sevoflurane Inhalation as Well as Normal Rats Do.
    PLoS One. 2016;11:e0154154.
    PubMed     Text format     Abstract available


  67. PAGANO JJ, Chow K, Khan A, Michelakis E, et al
    Reduced Right Ventricular Native Myocardial T1 in Anderson-Fabry Disease: Comparison to Pulmonary Hypertension and Healthy Controls.
    PLoS One. 2016;11:e0157565.
    PubMed     Text format     Abstract available


  68. WANG Q, Guo YZ, Zhang YT, Xue JJ, et al
    The Effects and Mechanism of Atorvastatin on Pulmonary Hypertension Due to Left Heart Disease.
    PLoS One. 2016;11:e0157171.
    PubMed     Text format     Abstract available


  69. YANG L, Yu D, Mo R, Zhang J, et al
    The Succinate Receptor GPR91 Is Involved in Pressure Overload-Induced Ventricular Hypertrophy.
    PLoS One. 2016;11:e0147597.
    PubMed     Text format     Abstract available


  70. HUANG WC, Ke MW, Cheng CC, Chiou SH, et al
    Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial Hypertension.
    PLoS One. 2016;11:e0142476.
    PubMed     Text format     Abstract available


  71. NIELSEN EA, Sun M, Honjo O, Hjortdal VE, et al
    Dual Endothelin Receptor Blockade Abrogates Right Ventricular Remodeling and Biventricular Fibrosis in Isolated Elevated Right Ventricular Afterload.
    PLoS One. 2016;11:e0146767.
    PubMed     Text format     Abstract available


  72. WEST JD, Carrier EJ, Bloodworth NC, Schroer AK, et al
    Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension.
    PLoS One. 2016;11:e0148657.
    PubMed     Text format     Abstract available


  73. PARIKH RV, Ma Y, Scherzer R, Heringer AS, et al
    Endothelin-1 Predicts Hemodynamically Assessed Pulmonary Arterial Hypertension in HIV Infection.
    PLoS One. 2016;11:e0146355.
    PubMed     Text format     Abstract available


  74. GALAMBOS C, Minic AD, Bush D, Nguyen D, et al
    Increased Lung Expression of Anti-Angiogenic Factors in Down Syndrome: Potential Role in Abnormal Lung Vascular Growth and the Risk for Pulmonary Hypertension.
    PLoS One. 2016;11:e0159005.
    PubMed     Text format     Abstract available


  75. AL-ALLAWI N, Mohammad AM, Jamal S
    Doppler-Defined Pulmonary Hypertension in Sickle Cell Anemia in Kurdistan, Iraq.
    PLoS One. 2016;11:e0162036.
    PubMed     Text format     Abstract available


  76. JUJO T, Tanabe N, Sakao S, Ishibashi-Ueda H, et al
    Severe Pulmonary Arteriopathy Is Associated with Persistent Hypoxemia after Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.
    PLoS One. 2016;11:e0161827.
    PubMed     Text format     Abstract available


  77. RENGIER F, Worz S, Melzig C, Ley S, et al
    Automated 3D Volumetry of the Pulmonary Arteries based on Magnetic Resonance Angiography Has Potential for Predicting Pulmonary Hypertension.
    PLoS One. 2016;11:e0162516.
    PubMed     Text format     Abstract available


  78. COLLACO JM, Dadlani GH, Nies MK, Leshko J, et al
    Risk Factors and Clinical Outcomes in Preterm Infants with Pulmonary Hypertension.
    PLoS One. 2016;11:e0163904.
    PubMed     Text format     Abstract available


  79. RICHTER MJ, Tiede SL, Sommer N, Schmidt T, et al
    Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension.
    PLoS One. 2016;11:e0165982.
    PubMed     Text format     Abstract available


  80. SUGIMOTO K, Yoshihisa A, Nakazato K, Jin Y, et al
    Pulmonary Arterial Capacitance Predicts Cardiac Events in Pulmonary Hypertension Due to Left Heart Disease.
    PLoS One. 2016;11:e0165603.
    PubMed     Text format     Abstract available


  81. JANKOWICH M, Elston B, Evans SK, Wu WC, et al
    Relationship of Iron Deficiency and Serum Ferritin Levels with Pulmonary Hypertension: The Jackson Heart Study.
    PLoS One. 2016;11:e0167987.
    PubMed     Text format     Abstract available


  82. KOVACS G, Avian A, Foris V, Tscherner M, et al
    Use of ECG and Other Simple Non-Invasive Tools to Assess Pulmonary Hypertension.
    PLoS One. 2016;11:e0168706.
    PubMed     Text format     Abstract available


  83. WANG L, Qu M, Chen Y, Zhou Y, et al
    Statins Have No Additional Benefit for Pulmonary Hypertension: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0168101.
    PubMed     Text format     Abstract available


  84. PARK DW, Sebastiani A, Yap CH, Simon MA, et al
    Quantification of Coupled Stiffness and Fiber Orientation Remodeling in Hypertensive Rat Right-Ventricular Myocardium Using 3D Ultrasound Speckle Tracking with Biaxial Testing.
    PLoS One. 2016;11:e0165320.
    PubMed     Text format     Abstract available


  85. FARHA S, Hu B, Comhair S, Zein J, et al
    Mitochondrial Haplogroups and Risk of Pulmonary Arterial Hypertension.
    PLoS One. 2016;11:e0156042.
    PubMed     Text format     Abstract available


  86. SAHOO S, Meijles DN, Al Ghouleh I, Tandon M, et al
    MEF2C-MYOCD and Leiomodin1 Suppression by miRNA-214 Promotes Smooth Muscle Cell Phenotype Switching in Pulmonary Arterial Hypertension.
    PLoS One. 2016;11:e0153780.
    PubMed     Text format     Abstract available


  87. WU Y, Adi D, Long M, Wang J, et al
    4-Phenylbutyric Acid Induces Protection against Pulmonary Arterial Hypertension in Rats.
    PLoS One. 2016;11:e0157538.
    PubMed     Text format     Abstract available


  88. ROSE JA, Wanner N, Cheong HI, Queisser K, et al
    Flow Cytometric Quantification of Peripheral Blood Cell beta-Adrenergic Receptor Density and Urinary Endothelial Cell-Derived Microparticles in Pulmonary Arterial Hypertension.
    PLoS One. 2016;11:e0156940.
    PubMed     Text format     Abstract available


  89. BUJAK R, Mateo J, Blanco I, Izquierdo-Garcia JL, et al
    New Biochemical Insights into the Mechanisms of Pulmonary Arterial Hypertension in Humans.
    PLoS One. 2016;11:e0160505.
    PubMed     Text format     Abstract available


    January 2015
  90. LAI YJ, Chang GJ, Yeh YH, Pang JH, et al
    Propylthiouracil Attenuates Experimental Pulmonary Hypertension via Suppression of Pen-2, a Key Component of Gamma-Secretase.
    PLoS One. 2015;10:e0137426.
    PubMed     Text format     Abstract available


  91. KOHYAMA T, Moriyama K, Kanai R, Kotani M, et al
    Correction: Accuracy of Pulse Oximeters in Detecting Hypoxemia in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    PLoS One. 2015;10:e0141944.
    PubMed     Text format     Abstract available


  92. HOEPER MM, Behr J, Held M, Grunig E, et al
    Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.
    PLoS One. 2015;10:e0141911.
    PubMed     Text format     Abstract available


  93. MCCULLAGH BN, Costello CM, Li L, O'Connell C, et al
    Elevated Plasma CXCL12alpha Is Associated with a Poorer Prognosis in Pulmonary Arterial Hypertension.
    PLoS One. 2015;10:e0123709.
    PubMed     Text format     Abstract available


  94. OTSUKI S, Sawada H, Yodoya N, Shinohara T, et al
    Potential contribution of phenotypically modulated smooth muscle cells and related inflammation in the development of experimental obstructive pulmonary vasculopathy in rats.
    PLoS One. 2015;10:e0118655.
    PubMed     Text format     Abstract available


  95. AGUERO J, Ishikawa K, Fish KM, Hammoudi N, et al
    Combination proximal pulmonary artery coiling and distal embolization induces chronic elevations in pulmonary artery pressure in Swine.
    PLoS One. 2015;10:e0124526.
    PubMed     Text format     Abstract available


  96. PROVENCHER S, Paruchuru P, Spezzi A, Waterhouse B, et al
    Quality of life, safety and efficacy profile of thermostable flolan in pulmonary arterial hypertension.
    PLoS One. 2015;10:e0120657.
    PubMed     Text format     Abstract available


  97. SWIFT AJ, Capener D, Hammerton C, Thomas SM, et al
    Right ventricular sex differences in patients with idiopathic pulmonary arterial hypertension characterised by magnetic resonance imaging: pair-matched case controlled study.
    PLoS One. 2015;10:e0127415.
    PubMed     Text format     Abstract available


  98. KIMURA M, Tamura Y, Takei M, Yamamoto T, et al
    Rapid initiation of intravenous epoprostenol infusion is the favored option in patients with advanced pulmonary arterial hypertension.
    PLoS One. 2015;10:e0121894.
    PubMed     Text format     Abstract available


  99. WILSON JL, Yu J, Taylor L, Polgar P, et al
    Hyperplastic Growth of Pulmonary Artery Smooth Muscle Cells from Subjects with Pulmonary Arterial Hypertension Is Activated through JNK and p38 MAPK.
    PLoS One. 2015;10:e0123662.
    PubMed     Text format     Abstract available


  100. VIALES RR, Eichstaedt CA, Ehlken N, Fischer C, et al
    Mutation in BMPR2 Promoter: A 'Second Hit' for Manifestation of Pulmonary Arterial Hypertension?
    PLoS One. 2015;10:e0133042.
    PubMed     Text format     Abstract available


  101. ZHAO YD, Chu L, Lin K, Granton E, et al
    A Biochemical Approach to Understand the Pathogenesis of Advanced Pulmonary Arterial Hypertension: Metabolomic Profiles of Arginine, Sphingosine-1-Phosphate, and Heme of Human Lung.
    PLoS One. 2015;10:e0134958.
    PubMed     Text format     Abstract available


  102. YAMAMURA A, Ohara N, Tsukamoto K
    Inhibition of Excessive Cell Proliferation by Calcilytics in Idiopathic Pulmonary Arterial Hypertension.
    PLoS One. 2015;10:e0138384.
    PubMed     Text format     Abstract available


  103. HAN QJ, Witschey WR, Fang-Yen CM, Arkles JS, et al
    Altered Right Ventricular Kinetic Energy Work Density and Viscous Energy Dissipation in Patients with Pulmonary Arterial Hypertension: A Pilot Study Using 4D Flow MRI.
    PLoS One. 2015;10:e0138365.
    PubMed     Text format     Abstract available


  104. ELGENDI M, Kumar S, Guo L, Rutledge J, et al
    Detection of Heart Sounds in Children with and without Pulmonary Arterial Hypertension-Daubechies Wavelets Approach.
    PLoS One. 2015;10:e0143146.
    PubMed     Text format     Abstract available


    January 2014
  105. POUSADA G, Baloira A, Vilarino C, Cifrian JM, et al
    Novel Mutations in BMPR2, ACVRL1 and KCNA5 Genes and Hemodynamic Parameters in Patients with Pulmonary Arterial Hypertension.
    PLoS One. 2014;9:e100261.
    PubMed     Text format     Abstract available


  106. SADAMURA-TAKENAKA Y, Ito T, Noma S, Oyama Y, et al
    HMGB1 Promotes the Development of Pulmonary Arterial Hypertension in Rats.
    PLoS One. 2014;9:e102482.
    PubMed     Text format     Abstract available


  107. SUN LY, Zhao H, Kang Y, Shen XD, et al
    Two-dimensional echocardiography in the assessment of long-term prognosis in patients with pulmonary arterial hypertension.
    PLoS One. 2014;9:e114443.
    PubMed     Text format     Abstract available


  108. BREDA AP, Pereira de Albuquerque AL, Jardim C, Morinaga LK, et al
    Skeletal muscle abnormalities in pulmonary arterial hypertension.
    PLoS One. 2014;9:e114101.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: